Ratanarat Ranistha, Hantaweepant Chattree, Tangkawattanakul Nattakarn, Permpikul Chairat
Department of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
J Med Assoc Thai. 2009 Mar;92 Suppl 2:S61-7.
The Acute Dialysis Quality Initiative (ADQI) Group published a consensus definition (the RIFLE criteria) for acute renal failure. We sought to assess the ability of the RIFLE criteria to predict mortality in critically ill Thai patients with acute kidney injury (AKI).
We performed a retrospective cohort study, in Siriraj Hospital (a large single tertiary care academic center in Thailand) on 121 patients admitted during November 2005-November 2006. We classified patients according to the maximum RIFLE class (class R, class I or class F) reached during their hospital stay. Demographic data, hospital mortality, hospital length of stay, and need of renal replacement therapy was collected.
Patients with maximum RIFLE class R, class I and class F had hospital mortality rates of 35.7%, 35.7% and 65.9%, respectively, compared with 20% for patients without acute kidney injury. Overall hospital mortality of the patients in AKI group (Risk, Injury, Failure group) was increased when compared with no AKI group (Odds ratio = 4.2; 95% Confidence Interval, 1.6-10.6; p =0.003). Mortality was not significantly different among those with the "Risk" and "Injury" class of RIFLE AKI compared with those without AKI, but mortality increased significantly with the "Failure" class (Odds ratio = 7.7; 95% Confidence Interval, 2.7-21.8; p < 0.001). There was the highest rate of renal replacement therapy in the failure group (52.3%) compared with no AKI group (5.7%), and injury group (7.1%) (p < 0.001).
Acute kidney injury 'risk, injury, failure', as defined by the newly developed RIFLE classification, is associated with increased hospital mortality and renal replacement therapy in critically ill Thai patients.
急性透析质量倡议(ADQI)小组发布了急性肾衰竭的共识定义(RIFLE标准)。我们旨在评估RIFLE标准预测泰国重症急性肾损伤(AKI)患者死亡率的能力。
我们在诗里拉吉医院(泰国一家大型三级医疗学术中心)对2005年11月至2006年11月期间收治的121例患者进行了回顾性队列研究。我们根据患者住院期间达到的最高RIFLE分级(R级、I级或F级)对患者进行分类。收集了人口统计学数据、医院死亡率、住院时间以及肾脏替代治疗需求。
最高RIFLE分级为R级、I级和F级的患者医院死亡率分别为35.7%、35.7%和65.9%,而无急性肾损伤患者的死亡率为20%。与无急性肾损伤组相比,急性肾损伤组(风险、损伤、衰竭组)患者的总体医院死亡率有所增加(比值比=4.2;95%置信区间,1.6 - 10.6;p = 0.003)。RIFLE急性肾损伤“风险”和“损伤”级别的患者与无急性肾损伤患者相比,死亡率无显著差异,但“衰竭”级别的患者死亡率显著增加(比值比=7.7;95%置信区间,2.7 - 21.8;p < 0.001)。与无急性肾损伤组(5.7%)和损伤组(7.1%)相比,衰竭组肾脏替代治疗率最高(52.3%)(p < 0.001)。
新制定的RIFLE分类所定义的急性肾损伤“风险、损伤、衰竭”与泰国重症患者医院死亡率增加及肾脏替代治疗有关。